Walleye Trading’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,068
Closed -$72.1K 5098
2023
Q2
$72.1K Sell
1,068
-1,764
-62% -$730K ﹤0.01% 3860
2023
Q1
$1.32M Buy
+2,832
New +$1.5M ﹤0.01% 2002
2021
Q4
Sell
-2,536
Closed -$648K 5502
2021
Q3
$648K Buy
2,536
+2,496
+6,240% +$884K ﹤0.01% 2674
2021
Q2
$27K Buy
+40
New +$23K ﹤0.01% 4775
2021
Q1
Sell
-252
Closed -$234K 4945
2020
Q4
$234K Buy
252
+176
+232% +$185K ﹤0.01% 3380
2020
Q3
$78K Buy
76
+40
+111% +$43K ﹤0.01% 3485
2020
Q2
$36K Sell
36
-188
-84% -$175K ﹤0.01% 3875
2020
Q1
$195K Sell
224
-308
-58% -$306K ﹤0.01% 2615
2019
Q4
$570K Buy
532
+400
+303% +$408K ﹤0.01% 2299
2019
Q3
$122K Sell
132
-188
-59% -$206K ﹤0.01% 3238
2019
Q2
$361K Buy
+320
New +$350K ﹤0.01% 2463
2018
Q4
Sell
-344
Closed -$522K 4845
2018
Q3
$522K Buy
344
+192
+126% +$296K ﹤0.01% 2849
2018
Q2
$238K Sell
152
-200
-57% -$261K ﹤0.01% 3510
2018
Q1
$407K Buy
+352
New +$464K ﹤0.01% 2868

Other funds holding KYNB

Walleye Trading's KYNB Position: Q2 2023 in Review

Walleye Trading sold out of Kyntra Bio (KYNB) in Q2 2023, closing a stake of 246 shares — an estimated $102K sold.

Walleye Trading first reported a position in KYNB in Q2 2016 and held it in 13 quarters. The position peaked at $1.47M in Q2 2021. 152 funds tracked by Wall St. Rank hold KYNB as of Q2 2023.

  • Walleye Trading reported no remaining Kyntra Bio position as of Q2 2023 after selling out during the quarter.
  • Walleye Trading sold 246 Kyntra Bio shares in Q2 2023, an estimated $102K.
  • Walleye Trading first reported a position in Kyntra Bio in Q2 2016 and held it in 13 quarters.
  • Walleye Trading's Kyntra Bio position peaked at $1.47M in Q2 2021.
  • 152 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2023.

Based on Walleye Trading's 13F filing for Q2 2023, filed 14 Aug 2023.